Cargando…
Is tumor (R)ejection by the immune system the “5th R” of radiobiology?
Traditional factors of DNA damage and tumor cell kill, described by the “4 R’s” of radiobiology (Reassortment, Reoxygenation, Repair, and Repopulation) fall short in explaining the role of immunity in hosts treated with radiotherapy. We propose a “5th R,” (immune-mediated) Rejection, which recognize...
Autores principales: | Golden, Encouse B, Formenti, Silvia C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008452/ https://www.ncbi.nlm.nih.gov/pubmed/24800177 http://dx.doi.org/10.4161/onci.28133 |
Ejemplares similares
-
Exploiting the stress response to radiation to sensitize poorly immunogenic tumors to anti-CTLA-4 treatment
por: Demaria, Sandra, et al.
Publicado: (2013) -
The 6th R of Radiobiology: Reactivation of Anti-Tumor Immune Response
por: Boustani, Jihane, et al.
Publicado: (2019) -
Inducing DNA damage through R-loops to kill cancer cells
por: Lam, Fred C., et al.
Publicado: (2020) -
The TLR7 agonist imiquimod as an adjuvant for radiotherapy-elicited in situ vaccination against breast cancer
por: Demaria, Sandra, et al.
Publicado: (2013) -
Emerging evidence of anti-tumor immune control in the central nervous system
por: Donson, Andrew M., et al.
Publicado: (2012)